TCS, HDFCBANK, SBI Liquid Fund (G)
SMS Lifesciences India Ltd.
SMS Lifesciences
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 07 06 2021 | Quarterly Results & Dividend & Audited Results |
| 18 06 2021 | Quarterly Results (Revised) & Dividend (Revised) & Audited Results |
| 13 08 2021 | Quarterly Results |
| 02 09 2021 | Inter alia, to consider the following: i) approval of the Board Report for the year 2020-21, ii) fixing the date of 15th Annual General Meeting, iii) appointment of Director, iv) any other items as may be decided by the Board of Directors. |
| 13 11 2021 | Quarterly Results |
| 30 11 2021 | Inter alia, to consider the following: i) Disinvestment of equity shares of Mahi Drugs Private Limited, a wholly-owned subsidiary of the Company and such other connected mailers thereof. ii) Any other items a s may be d ecided by the Board of Directors. |
| 11 02 2022 | Quarterly Results |
| 28 05 2022 | Dividend & Audited Results |
| 09 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 10 02 2023 | Quarterly Results |
| 29 05 2023 | Dividend & Audited Results |
| 08 08 2023 | A.G.M. & Quarterly Results |
| 11 11 2023 | Quarterly Results |
| 10 02 2024 | Quarterly Results & Independent Director Meeting |
| 13 11 2024 | Quarterly Results |
| 12 02 2025 | Quarterly Results & Independent Director Meeting |
News
No News data available
